Veto of Global Studies. In connection with any Global Study proposed to be conducted by the Developing Party, the Non-Developing Party shall have the right, by providing written notice to the Developing Party of the grounds for such objection, to object to the study taking place on the grounds that, in its reasonable opinion, the protocol design or conduct of the Global Study is reasonably likely to create a safety risk or otherwise have a material adverse impact on the Commercialization of the Product in the territory of the Non-Developing Party. In the event of dispute on this subject, either Party may refer the matter for escalation to the Senior Officers under the procedures in Section 5.6. If the Senior Officers fail to resolve the dispute, the decision of the Non-Developing Party shall be final on all issues.
Appears in 5 contracts
Samples: Buy in License Agreement, Buy in License Agreement (Ariad Pharmaceuticals Inc), Buy in License Agreement (Incyte Corp)